GERON CORP Investment Owned, Balance, Shares
GERON CORP (GERN) had Investment Owned, Balance, Shares of 0 shares as of 2021-03-31, per its 10-K filed 2024-02-28.
Discontinued › Notes
us-gaap:InvestmentOwnedBalanceShares · last filed 2024-02-28
- 2021-03-31: Investment Owned, Balance, Shares 0.00 shares.
- 2020-12-31: Investment Owned, Balance, Shares 688.93K shares.
- 2020-08-03: Investment Owned, Balance, Shares 35.99M shares.
- 2007-12-31: Investment Owned, Balance, Shares 13.84M shares.
| Period end | Investment Owned, Balance, Shares |
|---|---|
| 2021-03-31 | 0.00 shares 10-K · filed 2024-02-28 |
| 2020-12-31 | 688.93K shares 10-K · filed 2022-03-10 |
| 2020-08-03 | 35.99M shares 10-K · filed 2024-02-28 |
| 2007-12-31 | 13.84M shares 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |